Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.

Table of Contents

• The new abnormal: Practice in the COVID-19 era and beyond Rob Volansky
• Petition, medical societies urge nationwide mask mandate Janel Miller
• COVID-19 presents clinicians with an ‘immunology boot camp’ Leonard H. Calabrese, DO
• Disconnect amid dual diagnosis: Managing the mental toll of psoriasis, PsA Rob Volansky
• Global Rheumatology Alliance registry delivers 'reassuring' data, dispels COVID-19 myths Rob Volansky
• Spondylitis Association of America shines a light on 'critical public health issue' Rob Volansky
• ACR: Children at risk for uveitis should continue ophthalmology care despite COVID-19 Jason Laday
• ACR unveils guidance for multisystem inflammatory syndrome in children with COVID-19 Jason Laday
• Anakinra reduces ventilation need, mortality in COVID-19 Jason Laday
• Brief hiatus in baricitinib therapy led to minor RA symptom recurrence Jason Laday
• Coronary artery disease plus RA exacerbates risk for adverse CV events, mortality Jason Laday
• COVID-19 infection rate in patients treated with DMARDs consistent with general population Jason Laday
• Female patients with PsA have 2.3-fold increased risk for lupus Jason Laday
• Nearly 3 million children worldwide live with clubfoot, JIA or juvenile lupus Jason Laday
• Patients with fibromyalgia, OA, RA at increased risk for self-harm Jason Laday
• Risk for nonfatal CVD events 27% higher in Medicaid patients with SLE vs. diabetes Jason Laday
• Rituximab safe for long-term use in granulomatosis with polyangiitis, microscopic polyangiitis Jason Laday
• Rural patients with axSpA report greater disease impact on work productivity Jason Laday
• Serious infection-related hospitalization rates nearly doubled in vasculitis Jason Laday
• Steroid use increases COVID-19 hospitalization risk for patients with rheumatic diseases Jason Laday
• Tapering order of TNF inhibitors, DMARDs does not impact RA outcomes Jason Laday
• Women with rheumatic diseases want rheumatologists involved in sexual, reproductive health Jason Laday
• Clinicians managing IMIDs offer insights into pandemic as new COVID-19 cases mount Rob Volansky
• Expert: Effective COVID-19 therapies may be here by fall Jason Laday
• JAK inhibitors offer safe, effective 'patient-centric approach' to broad range of IMIDs Rob Volansky
• Managing cytokine storm requires 'important dialogue' among rheumatologists, specialists Rob Volansky
• ACR supports 'expanded role' for telemedicine in rheumatic care beyond COVID-19 Jason Laday
• Appeals court upholds Amgen victory in Enbrel fight; Sandoz eyes Supreme Court Jason Laday
• Black, Asian women with lupus less likely than white patients to receive contraception Jason Laday
• Nearly 25% of strong opioid use in RA may be attributed to obesity Jason Laday
• Opioids offer minimal benefit to pain, function in OA, no aid to QoL Jason Laday